Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Methadone tablets | ||
|
Methotrexate 2.5mg tablets | ||
|
Methotrexate injection | ||
|
Methotrexate | Specialist use only in neurological conditions |
|
|
Methoxy polyethelene glycol-epoetin beta (Mircera) | NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323. |
|
|
Methoxyflurane (Penthrox®) | For severe pain of traumatic origin and facilitation of management of significant fractures and dislocations |
|
|
Methoxypsoralen-5 20mg tablets | ||
|
Methyl aminolevulinate cream (Metvix®) | ||
|
Methylphenidate M/R tablets | Specialist initiation only, ESCA |
|
|
Methylphenidate tablets | ESCAs and additional advice in relation to age of patient and CCG |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
